Although the systemic or topical use of antibiotics and corticosteroid has been proved to be effective in the treatment of the EGFR inhibitor-associated skin rash, they are not suitable for long-term use due to their prominent side effects, including intestinal dysbacteriosis and the decline of immunity[6]. The gene discussed is EGFR; the disease is exanthem.